SEC Form 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|Estimated average burden|
|hours per response:
1. Name and Address of Reporting Person*
|11500 S. EASTERN AVE.|
2. Date of Event Requiring Statement
3. Issuer Name and Ticker or Trading Symbol
SPECTRUM PHARMACEUTICALS INC
[ SPPI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
||Officer (give title below)
||Other (specify below)
|SVP and Chief Legal Officer||
5. If Amendment, Date of Original Filed
6. Individual or Joint/Group Filing (Check Applicable Line)
||Form filed by One Reporting Person
||Form filed by More than One Reporting Person
|Table I - Non-Derivative Securities Beneficially Owned|
|1. Title of Security (Instr.
Amount of Securities Beneficially Owned (Instr.
||3. Ownership Form: Direct (D) or Indirect (I) (Instr.
||4. Nature of Indirect Beneficial Ownership (Instr.
Table II - Derivative Securities Beneficially Owned|
(e.g., puts, calls, warrants, options, convertible securities)
|1. Title of Derivative Security (Instr.
||2. Date Exercisable and Expiration Date
||3. Title and Amount of Securities Underlying Derivative Security (Instr.
||4. Conversion or Exercise Price of Derivative Security
||5. Ownership Form: Direct (D) or Indirect (I) (Instr.
||6. Nature of Indirect Beneficial Ownership (Instr.
||Amount or Number of Shares
|Explanation of Responses:|
|No securities are beneficially owned.|
||/s/ Kurt A. Gustafson, attorney-in-fact for Keith M. McGahan
||** Signature of Reporting Person
|Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.|
|* If the form is filed by more than one reporting person,
|** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).|
|Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
Instruction 6 for procedure.|
|Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.|
POWER OF ATTORNEY
I hereby authorize Joseph W. Turgeon, Kurt A. Gustafson and Thomas Riga,
acting singly, to sign and file on my behalf any and all forms required
by the Securities and Exchange Commission pursuant to Section 16 of the
Securities Exchange Act of 1934 (the "Exchange Act") relating to the
reporting of beneficial ownership of equity securities of Spectrum
Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and
of changes in such beneficial ownership, together with any and all
amendments thereto. This authorization shall be effective on and
after the date set forth below and shall continue in effect until
I am no longer required to file such forms, unless earlier revoked
by me in writing.
I acknowledge that the persons authorized hereunder are not assuming,
nor is the Company assuming, any of my responsibilities to comply
with Section 16 of the Exchange Act.
Dated as of this 1st day of June, 2018.
/s/ Keith M. McGahan
Keith M. McGahan